Skip to main content

Table 1 Baseline features of patients with myocardial infarction with type 1 diabetes or without any type of diabetes

From: Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction

 

All patients

Matched patients

 

Type 1 diabetes

No diabetes

  

Type 1 diabetes

No diabetes

  

Variable

n = 1508

n = 62,785

P value

|SMD|

n = 1401

n = 1401

P value

|SMD|

Age, years (SD)

61.2 (12.5)

68.7 (12.8)

 < 0.0001

0.587

61.8 (12.6)

62.2 (12.9)

0.255

0.035

Men

59.8%

65.4%

 < 0.0001

0.117

60.1%

59.7%

0.803

0.009

Co-morbidities

        

 Alcohol abuse

4.8%

3.1%

0.0004

0.084

4.7%

4.7%

1.000

 < 0.0001

 Atrial fibrillation

10.3%

13.1%

0.002

0.085

10.6%

10.3%

0.803

0.009

 Cerebrovascular disease

17.8%

9.7%

 < 0.0001

0.225

16.4%

16.3%

0.957

0.002

 Chronic pulmonary disease

11.7%

12.6%

0.306

0.027

12.0%

12.3%

0.817

0.009

 Coagulopathy

0.3%

0.4%

0.774

0.008

0.4%

0.2%

0.480

0.027

 Dementia

3.1%

4.2%

0.038

0.057

3.3%

3.4%

0.912

0.004

 Depression

15.8%

9.0%

 < 0.0001

0.207

14.7%

14.6%

0.956

0.002

 Heart failure

33.1%

15.9%

 < 0.0001

0.408

30.5%

29.4%

0.501

0.023

 Hypertension

72.5%

44.0%

 < 0.0001

0.604

70.6%

69.9%

0.612

0.016

 Liver disease

2.9%

0.9%

 < 0.0001

0.145

2.5%

2.7%

0.714

0.013

 Malignancy

10.4%

11.7%

0.113

0.042

10.7%

11.2%

0.664

0.016

 Paralysis

1.1%

0.4%

 < 0.0001

0.084

1.1%

1.1%

0.853

0.007

 Peripheral vascular disease

26.8%

5.5%

 < 0.0001

0.605

22.9%

23.1%

0.875

0.005

 Prior CABG

7.9%

2.7%

 < 0.0001

0.233

6.9%

6.6%

0.762

0.011

 Prior MI

21.1%

12.4%

 < 0.0001

0.234

19.7%

19.8%

0.921

0.004

 Psychotic disorder

3.3%

2.9%

0.357

0.023

3.3%

3.5%

0.753

0.012

 Rheumatic disease

6.7%

6.1%

0.373

0.023

6.9%

6.6%

0.762

0.011

 Renal failure

24.3%

1.9%

 < 0.0001

0.703

18.8%

19.7%

0.387

0.022

 Valvular disease

5.6%

5.2%

0.411

0.021

5.4%

6.3%

0.324

0.036

ST-elevation MI

30.2%

40.0%

 < 0.0001

0.205

31.3%

32.7%

0.363

0.031

 Anterior*

53.3%

46.7%

0.084

0.081

53.0%

50.7%

0.489

0.046

Revascularization

58.4%

62.7%

0.001

0.089

59.9%

60.7%

0.621

0.018

 PCI

48.3%

56.1%

 < 0.0001

0.156

49.8%

50.0%

0.934

0.003

 CABG

11.1%

7.3%

 < 0.0001

0.130

11.1%

11.3%

0.852

0.007

Post-MI medication

 ACEi or ARB

70.0%

68.0%

0.089

0.045

71.1%

71.5%

0.822

0.008

 Aldosterone antagonist

5.4%

3.3%

 < 0.0001

0.100

5.6%

6.2%

0.519

0.024

 Antiarrhythmic

1.2%

1.2%

0.871

0.004

1.1%

1.1%

1.000

 < 0.0001

 Beta-blocker

84.6%

84.5%

0.888

0.004

84.9%

86.5%

0.201

0.046

 Oral anticoagulant

11.7%

13.4%

0.058

0.051

12.0%

10.6%

0.224

0.045

 P2Y12 inhibitor

68.4%

70.0%

0.176

0.035

69.2%

70.3%

0.485

0.025

 Statin

81.8%

84.2%

0.012

0.064

83.3%

83.9%

0.264

0.042

University Hospital

55.5%

51.0%

0.001

0.099

55.0%

54.0%

0.547

0.022

Year of index MI

  

 < 0.0001

0.173

  

0.801

0.007

  1. Features of all patients and propensity score-matched cohort. CABG coronary artery bypass grafting surgery, MI myocardial infarction, PCI percutaneous coronary intervention, SMD standardized mean difference. *Of ST elevation MI patients